Membrane‐associated Lymphotoxin Expression and Functional Analysis of Lymphokine‐activated Killer Cells Derived from Tumor‐infiltrating Lymphocytes

The expression of a membrane‐associated lymphotoxin molecule (mLT) on lymphokine‐activated killer (LAK) cells obtained from 18 patients with malignant tumors and its role in the tumor cell killing mechanisms were investigated. LAK cells from tumor‐infiltrating lymphocytes (TIL‐LAK cells) were mainly composed of CD3‐positive cells, whereas LAK cells from peripheral blood lymphocytes (PBL‐LAK cells) were mainly composed of CD16‐ and CD56‐positive cells. However, mLT was found to be expressed on TIL‐LAK cells as well as PBL‐LAK cells. The degree of mLT expression correlated with the killing activity of LAK cells towards L929 cells (r=0.806, P<0.01, n = 15), but not with that towards Daudi or K562 cells. Although the degree of mLT expression correlated with the amount of secreted lymphotoxin (LT) in the supernatant of LAK cell culture, the secreted LT itself could not account for the tumor cell killing activity of LAK cells. Polyclonal rabbit anti‐LT antibody partially inhibited the killing activities of LAK cells towards L929 cells and this inhibition was found in the combination of autologous tumor cells and PBL‐LAK cells. These findings suggest the possibility that the mLT‐related cytotoxicity is involved in the tumor cell killing mechanisms of TIL‐LAK cells as well as PBL‐LAK cells.